101 related articles for article (PubMed ID: 27487326)
21. Elastic liposomes-in-vehicle formulations destined for skin therapy: the synergy between type of liposomes and vehicle.
Palac Z; Hurler J; Škalko-Basnet N; Filipović-Grčić J; Vanić Ž
Drug Dev Ind Pharm; 2015; 41(8):1247-53. PubMed ID: 25019501
[TBL] [Abstract][Full Text] [Related]
22. Deformable liposomes by reverse-phase evaporation method for an enhanced skin delivery of (+)-catechin.
Chen G; Li D; Jin Y; Zhang W; Teng L; Bunt C; Wen J
Drug Dev Ind Pharm; 2014 Feb; 40(2):260-5. PubMed ID: 23356860
[TBL] [Abstract][Full Text] [Related]
23. Transdermal delivery of flurbiprofen from surfactant-based vesicles: particle characterization and the effect of water on in vitro transport.
Uchino T; Matsumoto Y; Murata A; Oka T; Miyazaki Y; Kagawa Y
Int J Pharm; 2014 Apr; 464(1-2):75-84. PubMed ID: 24445120
[TBL] [Abstract][Full Text] [Related]
24. Development of vitamin loaded topical liposomal formulation using factorial design approach: drug deposition and stability.
Padamwar MN; Pokharkar VB
Int J Pharm; 2006 Aug; 320(1-2):37-44. PubMed ID: 16707237
[TBL] [Abstract][Full Text] [Related]
25. Physicochemical properties and skin permeation of Span 60/Tween 60 niosomes of ellagic acid.
Junyaprasert VB; Singhsa P; Suksiriworapong J; Chantasart D
Int J Pharm; 2012 Feb; 423(2):303-11. PubMed ID: 22155414
[TBL] [Abstract][Full Text] [Related]
26. Formulation optimization of estradiol microemulsion using response surface methodology.
Tsai YH; Fu LT; Huang CT; Chang JS; Huang YB; Wu PC
J Pharm Sci; 2011 Oct; 100(10):4383-9. PubMed ID: 21544822
[TBL] [Abstract][Full Text] [Related]
27. Effect of permeation enhancers on transdermal delivery of fluoxetine: in vitro and in vivo evaluation.
Jung E; Kang YP; Yoon IS; Kim JS; Kwon SW; Chung SJ; Shim CK; Kim DD
Int J Pharm; 2013 Nov; 456(2):362-9. PubMed ID: 24012861
[TBL] [Abstract][Full Text] [Related]
28. Niosomes vs microemulsions: new carriers for topical delivery of Capsaicin.
Tavano L; Alfano P; Muzzalupo R; de Cindio B
Colloids Surf B Biointerfaces; 2011 Oct; 87(2):333-9. PubMed ID: 21684725
[TBL] [Abstract][Full Text] [Related]
29. Optimizing glycerosome formulations
Zhu C; Zhang Y; Wu T; He Z; Guo T; Feng N
Acta Pharm; 2022 Mar; 72(1):135-146. PubMed ID: 36651523
[TBL] [Abstract][Full Text] [Related]
30. Formulation and in vitro assessment of minoxidil niosomes for enhanced skin delivery.
Balakrishnan P; Shanmugam S; Lee WS; Lee WM; Kim JO; Oh DH; Kim DD; Kim JS; Yoo BK; Choi HG; Woo JS; Yong CS
Int J Pharm; 2009 Jul; 377(1-2):1-8. PubMed ID: 19394413
[TBL] [Abstract][Full Text] [Related]
31. Characterization of cubosomes as a targeted and sustained transdermal delivery system for capsaicin.
Peng X; Zhou Y; Han K; Qin L; Dian L; Li G; Pan X; Wu C
Drug Des Devel Ther; 2015; 9():4209-18. PubMed ID: 26345516
[TBL] [Abstract][Full Text] [Related]
32. [Preparation and in vitro evaluations of topically applied capsaicin transfersomes].
Long XY; Luo JB; Li LR; Lin D; Rong HS; Huang WM
Zhongguo Zhong Yao Za Zhi; 2006 Jun; 31(12):981-4. PubMed ID: 17048643
[TBL] [Abstract][Full Text] [Related]
33. Transdermal potential and anti-arthritic efficacy of ursolic acid from niosomal gel systems.
Jamal M; Imam SS; Aqil M; Amir M; Mir SR; Mujeeb M
Int Immunopharmacol; 2015 Dec; 29(2):361-369. PubMed ID: 26545446
[TBL] [Abstract][Full Text] [Related]
34. Elastic liposomes mediated transdermal delivery of an anti-hypertensive agent: propranolol hydrochloride.
Mishra D; Garg M; Dubey V; Jain S; Jain NK
J Pharm Sci; 2007 Jan; 96(1):145-55. PubMed ID: 16960826
[TBL] [Abstract][Full Text] [Related]
35. Preparation of transfersomes encapsulating sildenafil aimed for transdermal drug delivery: Plackett-Burman design and characterization.
Ahmed TA
J Liposome Res; 2015 Mar; 25(1):1-10. PubMed ID: 25148294
[TBL] [Abstract][Full Text] [Related]
36. Development and optimization of boswellic acid-loaded proniosomal gel.
Mehta M; Dureja H; Garg M
Drug Deliv; 2016 Oct; 23(8):3072-3081. PubMed ID: 26953869
[TBL] [Abstract][Full Text] [Related]
37. A study on ethosomes as mode for transdermal delivery of an antidiabetic drug.
Bodade SS; Shaikh KS; Kamble MS; Chaudhari PD
Drug Deliv; 2013; 20(1):40-6. PubMed ID: 23311652
[TBL] [Abstract][Full Text] [Related]
38. Development of invaethosomes and invaflexosomes for dermal delivery of clotrimazole: optimization, characterization and antifungal activity.
Duangjit S; Takayama K; Bumrungthai S; Mahadlek J; Ngawhirunpat T; Opanasopit P
Pharm Dev Technol; 2023 Sep; 28(7):611-624. PubMed ID: 37357890
[TBL] [Abstract][Full Text] [Related]
39. Development of thermodynamically stable nanostructured lipid carrier system using central composite design for zero order permeation of econazole nitrate through epidermis.
Keshri L; Pathak K
Pharm Dev Technol; 2013; 18(3):634-44. PubMed ID: 22339250
[TBL] [Abstract][Full Text] [Related]
40. Optimization of the process variables of tilianin-loaded composite phospholipid liposomes based on response surface-central composite design and pharmacokinetic study.
Zeng C; Jiang W; Tan M; Yang X; He C; Huang W; Xing J
Eur J Pharm Sci; 2016 Mar; 85():123-31. PubMed ID: 26883760
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
